A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Liquidia Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 38,619 shares of LQDA stock, worth $622,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,619
Holding current value
$622,152
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$9.82 - $11.8 $379,238 - $455,704
38,619 New
38,619 $454,000
Q2 2022

Aug 15, 2022

BUY
$3.37 - $7.55 $52,848 - $118,399
15,682 New
15,682 $68,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.04B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.